胃内視鏡検査・診断に自信がつく本

出版社： 金芳堂
著者：
発行日： 2018-11-10
分野： 臨床医学：内科  >  胃/腸
ISBN： 9784765317634
電子書籍版： 2018-11-10 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

8,360 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

8,360 円(税込)

購入する

商品紹介

早期胃癌診断学のエッセンス＋トレーニング問題61症例！　本書では、胃内視鏡検査・診断に関する知識を新たにまとめ上げ（第1章＋関連知識）、胃粘膜を見る目・早期胃癌を拾い上げるための勘所を養うためのトレーニング問題を充実させた（第2章）。胃内視鏡検査において漫然とした「観察」状態から「探す」意識に視点が変わり、早期胃癌を的確に見極め、拾い上げ、質的診断まで自信をもって行うために必要なすべてが，この１冊に集約されている。

目次

  • 第１章：胃内視鏡検査・診断の基本
    　１．検査と診断のコツ
    　　1-1　胃の生理学
    　　1-2　胃癌の拾い上げに役立つ胃粘膜所見
    　　1-3　臨床における「胃炎の京都分類」の意義と使い方
    　　1-4　リスク層別化を考慮した観察のコツ
    　　1-5　ピロリ陰性胃癌の診かた?ピロリ未感染胃癌と除菌後胃癌
    　　1-6　見落としの少ない内視鏡の操作手順とコツ
    　　1-7　拡大観察の基礎知識
    　＜関連知識＞
    　　・ピロリ感染と胃癌発癌
    　　・対策型胃がん検診における胃内視鏡検診の目的と意義
    　　・早期胃癌典型例でのNBI・BLI画像の比較
    　２．検査前のポイント
    　　2-1　今だから必要な検査前の問診
    　　2-2　標準的な前処置法（咽頭麻酔や鎮痙剤の使用適応まで）
    　　2-3　抗血小板抗凝固の新ガイドラインを考慮した生検
    　　2-4　鎮静剤の使用について（ガイドラインに準ずる）
    　　2-5　経鼻内視鏡と経口内視鏡の選択について
    　＜関連知識＞
    　　・内視鏡検査におけるガイドラインと偶発症および医師の責任
    　　・偶発症と対応

    第２章：胃内視鏡検査・診断トレーニング問題
    　症例１―61
    　＜関連知識＞
    　　・Eカドヘリン遺伝子異常胃癌
    　　・LCIの有用性
    　　・ピロリ除菌後のPPI長期使用における異時性胃癌
    　　・EBウィルス関連胃癌

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 胃内視鏡検査・診断の基本

P.4 掲載の参考文献
1) 八木芳一. 正常胃粘膜の通常および拡大内視鏡像. 胃の拡大内視鏡診断 第2版 : 医学書院 ; 2014.
 
2) 太田浩良, 百瀬正信, 日高恵以子. 胃粘膜の正常構造. G. I. Research 1999 ; 7 : 139-43.
Medical*Online
3) 土橋康成, 藤田哲也. 血管構築. In : 川井啓一, 胃-形態とその機能 : 医学書院 ; 1975. p54-61.
 
4) Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects--a randomised open-label cross-over study. Aliment Pharmacol Ther 2015 ; 42 (6) : 719-30.
PubMed
P.14 掲載の参考文献
1) 中村恭一. "胃癌の三角" : 場と肉眼型と組織型. 胃と腸 1991 ; 26 : 15-25.
 
2) 中村恭一. 胃癌の構造第3版 : 医学書院 ; 2005.
 
3) 馬場保昌, 杉山憲義, 丸山雅一ほか. 陥凹性早期胃癌のX線所見と組織所見の比較. 胃と腸 1975 ; 10 : 37-49.
 
4) 馬場保昌, 吉田諭史. 発見例100例にみる胃癌X線診断の究極 : ベクトル・コア ; 2016.
 
5) Yamazato T, Oyama T, Yoshida T, et al. Two Years' intensive training in endoscopic diagnosis facilitates detection of early gastric cancer. Intern Med 2012 ; 51 (12) : 1461-5.
PubMed
6) Hosokawa O, Tsuda S, Kidani E, et al. Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy 1998 ; 30 (8) : 669-74.
PubMed
7) 小山恒男. 胃癌に対する内視鏡スクリーニング-私はこうしている. 胃と腸 2008 ; 43 : 1211-5.
 
8) 日本胃癌学会. 胃癌取扱い規約第15版 : 金原出版 ; 2017.
 
P.21 掲載の参考文献
1) Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001 ; 345 (11) : 784-9.
PubMed
2) Masuyama Y, Yoshitake N, Sasai T, et al. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk. Digestion 2015 ; 91 (1) : 30-36.
 
3) Sugimoto M, Ban H, Ichikawa H, et al. Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer. Intern Med 2017 ; 56 (6) : 579-86.
PubMed
4) 春間賢, 加藤元嗣, 井上和彦, 村上和成, 鎌田智有. 胃炎の京都分類 : 日本メディカルセンター ; 2014.
 
5) Watanabe M, Kato J, Inoue I, et al. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis. Int J Cancer 2012 ; 131 (11) : 2632-42.
PubMed
6) Nishibayashi H, Kanayama S, Kiyohara T, et al. Helicobacter pylori-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma. J Gastroenterol Hepatol 2003 ; 18 (12) : 1384-91.
 
7) Yamamichi N, Hirano C, Ichinose M, et al. Atrophic gastritis and enlarged gastric folds diagnosed by double-contrast upper gastrointestinal barium X-ray radiography are useful to predict future gastric cancer development based on the 3-year prospective observation. Gastric Cancer 2016 ; 19 (3) : 1016-22.
 
8) Kamada T, Tanaka A, Yamanaka Y, et al. Nodular gastritis with Helicobacter pylori infection is strongly associated with diffuse-type gastric cancer in young patients. Dig Endosc 2007 ; 19 (4) : 180-4.
 
9) 加藤元嗣. 第3章 胃癌リスクを考慮した内視鏡所見スコア-1 解説. In : 春間賢. 胃炎の京都分類 : 日本メディカルセンター ; 2014. p99-103.
 
10) Matsuo T, Ito M, Takata S, et al. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter 2011 ; 16 (6) : 415-9.
PubMed
11) Ono S, Kato M, Suzuki M, et al. Frequency of Helicobacter pylori-negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion 2012 ; 86 (1) : 59-65.
 
12) Nagata N, Shimbo T, Akiyama J, et al. Predictability of Gastric Intestinal Metaplasia by Mottled Patchy Erythema Seen on Endoscopy. Gastroenterology Res 2011 ; 4 (5) : 203-9.
PubMed
13) Watanabe K, Nagata N, Nakashima R, et al. Predictive findings for Helicobacter pylori-uninfected, -infected and -eradicated gastric mucosa : validation study. World J Gastroenterol 2013 ; 19 (27) : 4374-9.
 
14) Moribata K, Kato J, Iguchi M, et al. Endoscopic features associated with development of metachronous gastric cancer in patients who underwent endoscopic resection followed by Helicobacter pylori eradication. Dig Endosc 2016 ; 28 : 434-42.
 
15) 鎌田智有, 間部克裕, 深瀬和利ほか. H. pylori除菌後に発見された胃癌症例の臨床病理学的特徴-多施設集計100症例の検討から. 胃と腸 2008 ; 43 : 1810-19.
 
16) 日本ヘリコバクター学会ガイドライン作成委員会. H.pylori感染の診断と治療のガイドライン 2016改訂版 : 先端医学社 ; 2016.
 
17) 日本ヘリコバクター学会 : 「血清抗H.pylori IgG抗体検査」の陽性・陰性判定に関する日本ヘリコバクター学会からの注意喚起. [http://www.jshr.jp/pdf/info/topics/20150630_igg.pdf].
 
P.30 掲載の参考文献
1) 春間賢, 加藤元嗣, 井上和彦, 村上和成, 鎌田智有. 胃炎の京都分類 : 日本メディカルセンター ; 2014.
 
2) 井上和彦, 谷充理, 吉原正治. 血清ペプシノゲン法とヘリコバクターピロリ抗体価を用いた胃の '健康度' 評価-同日に行った内視鏡検査を基準として-. 日本消化器集団検診学会雑誌 2005 ; 43 : 332-39.
 
3) Inoue K, Fujisawa T, Haruma K. Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies. Int J Biol Markers 2010 ; 25 (4) : 207-12.
PubMed
4) 井上和彦, 藤澤智雄, 西隆司ほか. ABC分類の有用性と問題点-ペプシノゲンの正常値の検討も含めて-. Helicobacter Research 2011 : 15 ; 422-27.
 
5) Inoue K. Stratification of gastric cancer risk by H.pylori infection. Suzuki H, Warren R, Marshall B, editors, Helicobacter pylori : Springer Japan ; 2016. p169-79.
 
6) Terasawa T, Nishida H, Kato K, et al. Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians : a systematic review and meta-analysis. PLoS One 2014 ; 9 (10) : e109783.
PubMed
7) Miki K, Ichinose M, Shimizu A, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroentereol Jpn 1987 ; 22 (2) : 133-41.
PubMed
8) 井上和彦. 胃がんリスク層別化検査 (ABC分類) 2016年度改訂版の提案～運用におけるE-プレート '栄研' H. ピロリ IIの判定基準の変更を中心に～ . Gastro-Health Now 2016増刊号 : p 1-3 .
 
9) 井上和彦, 鎌田智有, 塚本真知ほか. 胃炎の臨床診断-血清診断. 胃と腸 2016 ; 51 : 64-71.
 
10) 井上和彦. 胃癌スクリーニングとしてのペプシノゲン法 : 人間ドック内視鏡検査との同時検討から (1). In : 三木一正. ペプシノゲン法 : 医学書院 ; 1998. p196-200.
 
11) Kamada T, Hata J, Sugiu K, et al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori : results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther 2005 ; 21 (9) : 1121-6.
PubMed
12) Take S, Mizuno M, Ishiki K, et al. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol 2011 ; 46 (3) : 318-24.
 
13) 井上和彦, 鎌田智有, 久本信實ほか. H.pylori陰性時代の胃癌スクリーニングのあり方. 消化器内視鏡 2018 ; 30 : 37-46.
Medical*Online
P.36 掲載の参考文献
1) 春間賢, 加藤元嗣, 井上和彦, 村上和成, 鎌田智有. 胃炎の京都分類 : 日本メディカルセンター ; 2014.
 
2) Horiuchi Y, Fujisaki J, Yamamoto N, et al. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer : comparison with Helicobacter pylori-positive early gastric cancer. Gastric Cancer 2016 ; 19 (1) : 160-5.
 
3) Ueyama H, Yao T, Nakashima Y, et al. Gastric adenocarcinema of fundic gland type (chief cell predominant type) : proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol 2010 ; 34 (5) : 609-19.
PubMed
4) 武進, 石木邦治, 水野元夫. Helicobacter pylori除菌後に発見される胃癌. 癌と化学療法 2011 ; 38 : 353-7 .
Medical*Online
5) Saka A, Yagi K, Nimura S. Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy. Gastric cancer 2016 ; 19 (2) : 524-30.
 
P.47 掲載の参考文献
1) 公益財団法人がん研究振興財団. がんの統計 '17, 2017.
 
2) 国立がん研究センター, がん予防検診研究センター. 有効性評価に基づく胃がん検診ガイドライン 2014年度版, 2015.
 
3) Yao K, Nagahama T, Matsui T, Iwashita A. Detection and characterization of early gastric cancer for curative endoscopic submucosal dissection. Dig Endosc 2013 ; 25 (1) : 44-54.
 
4) Bisschops R, Areia M, Coron E, et al. Performance measures for upper gastrointestinal endoscopy : a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy 2016 ; 48 (9) : 843-64.
PubMed
5) 春間賢, 加藤元嗣, 井上和彦, 村上和成, 鎌田智有. 胃炎の京都分類 : 日本メディカルセンター ; 2014.
 
6) 小林正明, 成澤林太郎, 佐藤祐一ほか. 内視鏡治療後における異時性多発胃癌の発生リスクは永続しない. Gastroenterological Endoscopy 2012 ; 54 : 1498-1505.
 
P.54 掲載の参考文献
1) Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy 2009 ; 41 (5) : 462-7.
PubMed
2) Ezoe Y, Muto M, Uedo N, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology 2011 ; 141 (6) : 2017-25.
PubMed
3) Muto M, Yao K, Kaise M, et al. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G). Dig Endosc 2016 ; 28 (4) : 379-93.
PubMed
4) 八尾建史, 長浜孝, 松井敏幸. 胃粘膜微小血管構築像をターゲットにした胃拡大内視鏡観察手技. Gastroenterol Endosc 2008 ; 50 : 1145-53.
 
5) 八尾建史, 松井敏幸, 岩下明徳. 胃拡大内視鏡 : 日本メディカルセンター ; 2009.
 
6) Uedo N, Ishihara R, Iishi H, et al. A new method of diagnosing gastric intestinal metaplasia : narrow-band imaging with　magnifying endoscopy. Endoscopy 2006 ; 38 (8) : 819-24.
PubMed
7) Yao K, Iwashita A, Nambu M, et al. Nature of white opaque substance in gastric epithelial neoplasia as visualized by　magnifying endoscopy with narrow-band imaging. Dig Endosc 2012 ; 24 (6) : 419-25.
PubMed
8) Kanesaka T, Uedo N, Yao K, et al. A signifi cant feature of microvessels in magnifying narrow-band imaging for diagnosis of early gastric cancer. Endosc Int Open 2015 ; 3 (6) : E590-6.
 
9) Doyama H, Yoshida N, Tsuyama S, et al. The "white globe appearance" (WGA) : a novel marker for a correct diagnosis of early gastric cancer by magnifying endoscopy with narrow-band imaging (M-NBI). Endosc Int Open 2015 ; 3 (2) : E120-4.
PubMed
10) Yoshida N, Doyama H, Nakanishi H, et al. White globe appearance is a novel specifi c endoscopic marker for gastric cancer : A prospective study. Dig Endosc 2016 ; 28 (1) : 59-66.
 
11) Watanabe Y, Shimizu M, Itoh T, Nagashima K. Intraglandular necrotic debris in gastric biopsy and surgical specimens. Ann Diagn Pathol 2001 ; 5 (3) : 141-7.
PubMed
12) Yao K, Doyama H, Gotoda T, et al : Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer : a prospective multicenter feasibility study. Gastric Cancer 2014 : 17 ; 669-79.
PubMed
13) Yamada S, Doyama H, Yao K, et al. An efficient diagnostic strategy for small, depressed early gastric cancer with magnifying narrow-band imaging : a post-hoc analysis of a prospective randomized controlled trial. Gastrointest Endosc 2014 ; 79 (1) : 55-63.
PubMed
14) 八尾建史. 動画で学ぶ胃拡大内視鏡テクニック : 日本メディカルセンター ; 2012.
 
P.58 掲載の参考文献
1) 山下太郎, 菓裕貴, 磯本一. H. pylori感染と胃癌発癌-DNAメチル化異常を中心として. 消化器内視鏡 2017 ; 29 (7) : 1224-27.
 
2) Asada K, Nakajima T, Shimazu T, et al. Demonstration of the usefulness of epigenetic cancer risk prediction by a multicenter prospective cohort study. Gut 2015 ; 64 (3) : 388-96.
PubMed
3) 牛島俊和, 服部奈緒子, 山下聡. 胃発癌の分子機構. 日本消化器病学会雑誌 2016 : 113 ; 1868-77.
Medical*Online
4) Niwa T, Tsukamoto T, Toyoda T, et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res 2010 ; 70 (4) : 1430-40.
PubMed
5) Cai GH, Wang K, Miao Q, et al. Expression of polycomb protein EZH2 inmulti-stage tissues of gastric carcinogenesis. J Dig Dis 2010 ; 11 (2) : 88-93.
 
6) Pan YM, Wang CG, Zhu M, et al. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer. Mol Cancer 2016 ; 15 (1) : 79.
PubMed
7) Matsushima K, Isomoto H, Inoue N, et al. MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer 2011 ; 128 (2) : 361-70.
PubMed
8) The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014 ; 513 (7517) : 202-9.
 
9) Leodolter A, Alonso S, Gonzalez B, et al. Somatic DNA Hypomethylation in H. pylori-Associated High-Risk Gastritis and Gastric Cancer : Enhanced Somatic Hypomethylation Associates with Advanced Stage Cancer. Clin Transl Gastroenterol 2015 ; 6 : e85.
 
10) 中島健, 前田将宏, 森源喜ほか. ESD後除菌後胃癌とDNAメチル化異常. 胃と腸 2016 : 51 (6) ; 805-13.
 
P.61 掲載の参考文献
1) 厚生労働省. がん予防重点健康教育及びがん検診実施のための指針. 平成20年3月31日付け健発第0331058号厚生労働省健康局長通知別添. 2016.
 
2) 国立がん研究センター. がん予防・検診研究センター : 有効性評価に基づく胃がん検診ガイドライン 2014年度版. 2015.
 
3) Harris RP, Wilt TJ, Qaseem A. A value framework for cancer screening : advice for high-value care from the American College of Physicians. Ann Intern Med 2015 ; 162 (10) : 712-7.
PubMed
4) 日本消化器がん検診学会. 対策型検診のための胃内視鏡検診マニュアル : 南江堂 ; 2017.
 
5) Pepe MS, Etzioni R, Feng Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001 ; 93 (14) : 1054-61.
PubMed
6) 平成17年度 厚生労働省がん研究助成金がん検診の適切な方法とその評価法 : の確立に関する研究班 (主任研究者 祖父江友孝). 有効性評価に基づく胃がん検診ガイドライン. 2005.
 
7) Riecken B, Pfeiffer R, Ma JL, et al. No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk. Prev Med 2002 ; 34 (1) : 22-8.
 
8) Institute of Medicine. Clinical Practice Guidelines We Can Trust : The National Academies Press ; 2011
 
9) Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status : a prospective endoscopic cohort study. Gut 2005 ; 54 (6) : 764-8.
PubMed
10) Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models : a framework for traditional and novel measures. Epidemiology 2010 ; 21 (1) : 128-38.
PubMed
11) Hamashima C, Sasazuki S, Inoue M, et al. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests. BMC Cancer 2017 ; 17 (1) : 183.
PubMed
P.65 掲載の参考文献
1) 田尻久雄. 消化器内視鏡NBI症例集. オリンパスメディカルシステムズ ; 2010.
 
2) 八木信明, 内藤裕二ほか. 胃癌の内視鏡検査・診断 BLI (blue LASER imaging). 日本臨牀 72 (増刊号 1) 2014 ; 266-71.
 
3) Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy 2009 ; 41 (5) : 462-7.
PubMed
4) Dohi O, Yagi N, Majima A, et al. Diagnostic ability of magnifying endoscopy with blue laser imaging for early gastric cancer : a prospective study. Gastric Cancer 2017 ; 20 (2) : 297-303.
PubMed
5) Dohi O, Yagi N, Yoshida S, et al. Magnifying Blue Laser Imaging versus Magnifying Narrow-Band Imaging for the Diagnosis of Early Gastric Cancer : A Prospective, Multicenter, Comparative Study. Digestion 2017 ; 96 (3) : 127-34.
PubMed
6) Kimura-Tsuchiya R, Dohi O, Fujita Y, et al. Magnifying Endoscopy with Blue Laser Imaging Improves the Microstructure Visualization in Early Gastric Cancer : Comparison of Magnifying Endoscopy with Narrow-Band Imaging. Gastroenterol Res Pract 2017 ; 8303046
PubMed
P.67 掲載の参考文献
1) 藤本一眞, 藤城光弘, 加藤元嗣ほか. 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン. Gastroenterol Endosc 2012 ; 54 : 2075-102.
 
2) 加藤元嗣, 上堂文也, 掃本誠治ほか. 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン 直接経口抗凝固薬 (DOAC) を含めた抗凝固薬に関する追補 2017. Gastroenterol Endosc 2017 ; 59 : 1547-58.
 
P.71 掲載の参考文献
1) 水野順子. 上部消化管内視鏡検査の咽頭麻酔におけるリドカインビスカスとリドカインスプレーの麻酔効果と麻酔苦痛度の比較検討. 福島医学雑誌 2011 ; 61 (1).
 
2) 今川敦, 竹内圭子 吉田泰成ほか. 胃ESDにおけるミントオイル散布法の有用性と安全性の検討. Gastroenterological Endscopy 2012 ; 54 (12) : 3783-89.
 
3) Hiki N, Kaminishi M, Yasuda K, et al. Antiperistaltic effect and safety of L-menthol sprayed on the gastric mucosa for upper GI endoscopy : a phase III, multicenter, randomized, double-blind, placebo-controlled study. Gastrointest Endosc 2011 ; 73 (5) : 932-41.
PubMed
4) Fujisiro M, Kaminisi M, HIki N, et al. Efficacy of spraying l-menthol solution during endoscopic treatment of early gastric cancer : a phase III, multicenter, randomized, double-blind, placebo-controlled study. J Gastroenterol 2014 ; 49 (3) : 446-54.
 
P.77 掲載の参考文献
1) Miyanaga R, Hosoe N, Naganuma M, et al. Complications and outcomes of routine endoscopy in the very elderly. Endosc Int Open 2018 ; 6 (2) : E224-9.
PubMed
2) 藤本一眞, 藤城光弘, 加藤元嗣ほか. 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン. Gastroenterol Endosc 2012 ; 54 : 2075-102.
 
3) 加藤元嗣, 上堂文也, 掃本誠治ほか. 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン 直接経口抗凝固薬 (DOAC) を含めた抗凝固薬に関する追補 2017. Gastroenterol Endosc 2017 ; 59 : 1547-58.
 
4) Ono S, Fujishiro M, Kodashima S, et al. Evaluation of safety of endoscopic biopsy without cessation of antithrombotic agents in Japan. J Gastroenterol 2012 ; 47 (7) : 770-4.
PubMed
5) Fujita M, Shiotani A, Murao T, et al. Safety of gastrointestinal endoscopic biopsy in patients taking antithrombotics. Dig Endosc 2015 ; 27 (1) : 25-9.
PubMed
6) Ara N, Iijima K, Maejima R, et al. Prospective analysis of risk for bleeding after endoscopic biopsy without cessation of antithrombotics in Japan. Dig Endosc 2015 ; 27 (4) : 458-64.
PubMed
7) Choudari CP, Rajgopal C, Palmer KR. Acute gastrointestinal haemorrhage in anticoagulated patients : diagnoses and response to endoscopic treatment. Gut 1994 ; 35 (4) : 464-6.
PubMed
P.83 掲載の参考文献
1) McQuaid KR, Laine L. A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures. Gastrointest Endosc 2008 ; 67 (6) : 910-23.
 
2) Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology 2007 ; 133 (2) : 675-701.
PubMed
3) Abraham N, Barkun A, Larocque M, et al. Predicting which patients can undergo upper endoscopy comfortably without conscious sedation. Gastrointest Endosc 2002 ; 56 (2) : 180-9.
PubMed
4) Garcia RT, Cello JP, Nguyen MH, et al. Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD : a multicenter randomized trial. Gastroenterology 2003 ; 125 (6) : 1606-12.
PubMed
5) Yoshizawa T, Miwa H, Kojima T, et al. Low-dose flunitrazepam for conscious sedation for EGD : a randomized double-blind placebo-controlled study. Gastrointest Endosc 2003 ; 58 (4) : 523-30.
PubMed
6) Obara K, Haruma K, Irisawa A, et al. Guideline for sedation in gastroenterological endoscopy. Dig Endosc 2015 ; 27 (4) : 435-49.
PubMed
7) Lee MG, Hanna W, Harding H. Sedation for upper gastrointestinal endoscopy : a comparative study of midazolam and diazepam. Gastrointest Endosc 1989 ; 35 (2) : 82-4.
PubMed
P.89 掲載の参考文献
1) Kawai T, Yanagizawa K, Naito S, et al. Evaluation of gastric cancer diagnosis using new ultrathin transnasal endoscopy with narrow-band imaging : preliminary study. J Gastroenterol Hepatol 2014 ; 29 (4) : 33-6.
PubMed
2) Ai ZL, Lan CH, Fan LL, et al. Unsedated transnasal upper gastrointestinal endoscopy has favorable diagnostic effectiveness, cardiopulmonary safety, and patient satisfaction compared with conventional or sedated endoscopy. Surg Endosc 2012 ; 26 (12) : 3565-72.
PubMed
3) Kanzaki H, Takenaka R, Kawahara Y, et al. Linked color imaging (LCI), a novel image-enhanced endoscopy technology, emphasizes the color of early gastric cancer. Endosc Int Open 2017 ; 5 (10) : E1005-13.
PubMed
P.91 掲載の参考文献
1) 藤本一眞, 藤城光弘, 加藤元嗣ほか. 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン. Gastroenterol Endosc 2012 ; 54 : 2075-102.
 
2) 加藤元嗣, 上堂文也, 掃本誠治ほか. 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン直接経口抗凝固薬 (DOAC) を含めた抗凝固薬に関する追補 2017. Gastroenterol Endosc 2012 ; 59 : 1547-58.
 
3) 広島地裁呉支部平成13年11月30日判決. 裁判所ホームページ裁判例情報 [http://www.courts.go.jp/app/files/hanrei_jp/984/007984_hanrei.pdf]
 
P.93 掲載の参考文献
1) Yuki M, Amano Y, Komazawa Y, et al. Unsedated transnasal small-caliber esophagogastroduodenoscopy in elderly and bedridden patients. World J Gastroenterol 2009 ; 15 (44) : 5586-91.
PubMed
2) Kobayashi Y, Komazawa Y, Yuki M, et al. Use of anticoagulant or antiplatelet agents is not related to epistaxis in patients undergoing transnasal endoscopy. Endosc Int Open 2018 ; 6 (1) : E104-10.
 
3) 藤本一眞, 藤城光弘, 加藤元嗣ほか. 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン. Gastroenterol Endosc 2012 ; 54 : 2075-102.
 
4) Yuki T, Ishihara S, Yashima K, et al. Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy : A Multicenter Prospective Observational Study. Curr Ther Res Clin Exp 2017 ; 84 : 32-6.
PubMed

第2章 胃内視鏡検査・診断トレーニング問題

P.220 掲載の参考文献
1) Liu X, Chu KM. E-Cadherin and Gastric Cancer : Cause, Consequence, and applications. Biomed Res Int 2014 ; 637308.
 
2) The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014 ; 513 (7517) : 202-9.
 
3) Oliveira C, Pinheiro H, Figueiredo J, et al. Familial gastric cancer : genetic susceptibility, pathology, and implications for management. Lancet Oncol 2015 ; 16 (2) : e60-70.
 
4) van der Post RS, Vogelaar IP, Cameiro F, et al. Hereditary diffuse gastric cancer : updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 2015 ; 52 (6) : 361-74.
 
5) Humar B, Blair V, Charlton H, et al. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res 2009 ; 69 (5) : 2050-6.
 
6) Mimata A, Fukamachi H, Eishi Y, Yuasa Y. Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci 2011 ; 102 (5) : 942-50.
 
7) Shimada S, Mimata A, Sekine M, et al. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer. Gut 2012 ; 61 (3) : 344-53.
 
8) Hayakawa Y, Ariyama H, Stancikova J, et al. Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithlium and Are Supported by a Perivascular Stem Cell Niche. Cancer cell 2015 ; 28 (6) : 800-14.
 
P.224 掲載の参考文献
1) Dohi O, Yagi N, Onozawa Y, et al. Linked color imaging improves endoscopic diagnosis of active Helicobacter pylori infection. Endosc Int Open 2016 ; 4 (7) : E800- 5 .
 
2) Ono S, Kato M. Endoscopic Diagnosis of Gastric Intestinal Metaplasia Using Linked Color Imaging. Gastroenterol Endosc 2017 ; 59 (4) : 465-74.
 
3) Kato M, Terao S, Adachi K, et al. Changes in endoscopic findings of gastritis after cure of H. pylori infection : multicenter prospective trial. Dig Endosc 2013 ; 25 (3) : 264-73.
PubMed
4) Fukuda H, Miura Y, Hayashi Y, et al. Linked color imaging technology facilitates early detection of flat gastric cancers. Clin J Gastroenterol 2015 ; 8 (6) : 385- 9 .
 
5) Kanzaki H, Takenaka R, Kawahara Y, et al. Linked color imaging (LCI), a novel image-enhanced endoscopy technology, emphasizes the color of early gastric cancer. Endosc Int Open 2017 ; 5 (10) : E1005-13.
PubMed
6) Yoshifuku Y, Sanomura Y, Oka S, et al. Evaluation of the visibility of early gastric cancer using linked color imaging and blue laser imaging. BMC Gastroenterol 2017 ; 17 (1) : 150.
PubMed
P.227 掲載の参考文献
1) Lundell L, Vieth M, Gibson F, et al. Systematic review : the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology. Aliment Pharmacol Ther 2015 ; 42 (6) : 649-63.
PubMed
2) Tran-Duy A, Spaetgens B, Hoes AW, et al. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer : Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2016 ; 14 (12) : 1706-19.
PubMed
3) Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006 ; 296 (24) : 2947-53.
PubMed
4) Sehested TSG, Gerds TA, Fosbol EL, et al. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction. J Intern Med 2018 ; 283 (3) : 268-81.
PubMed
5) Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996 ; 334 (16) : 1018-22.
PubMed
6) Cheung KS, Chan EW, Wong AYS, et al. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori : a population-based study. Gut 2018 ; 67 (1) : 28-35.
PubMed
7) Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer : an open-label, randomised controlled trial. Lancet 2008 ; 372 (9636) : 392- 7 .
PubMed
8) Lee YC, Chiang TH, Chou CK, et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence : A Systematic Review and Meta-analysis. Gastroenterology 2016 ; 150 (5) : 1113-1124. e5.
 
9) Ford AC, Forman D, Hunt RH, et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals : systematic review and meta-analysis of randomised controlled trials. BMJ 2014 ; 348 : g3174.
PubMed
P.231 掲載の参考文献
1) Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 1990 ; 3 (3) : 377-80.
PubMed
2) Tokunaga M, Land CE, Uemura Y, et al. Epstein-Barr virus in gastric carcinoma. Am J Pathol 1993 ; 143 (5) : 1250-4.
PubMed
3) Imai S, Koizumi S, Sugiura M, et al. Gastric carcinoma : monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994 ; 91 (19) : 9131-5.
 
4) Murphy G, Pfeiffer R, Camargo MC, et al. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 2009 ; 137 (3) : 824-33.
PubMed
5) Tokunaga M, Uemura Y, Tokudome T, et al. Epstein-Barr virus related gastric cancer in Japan : a molecular pathoepidemiological study. Acta Pathol Jpn 1993 ; 43 (10) : 574-81.
PubMed
6) Yanai H, Nishikawa J, Mizugaki Y, et al. Endoscopic and pathologic feature of Epstein-Barr virus-associated gastric carcinoma. Gastrointest Endosc 1997 ; 45 (3) : 236-42.
PubMed
7) Nishikawa J, Yanai H, Hirano A, et al. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction. Scand J Gastroenterol 2002 ; 37 (7) : 825-9.
PubMed
8) Watanabe H, Enjouji M, Imai T. Gastric carcinoma with lymphoid stroma : Its morphologic characteristics and prognostic correlations. Cancer 1976 ; 38 (1) : 232-43.
 
9) 日本胃癌学会. 胃癌取扱い規約 第15版 : 金原出版 ; 2017.
 
10) The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014 ; 513 (7517) : 202-9.
 
11) Arikawa J, Tokunaga M, Satoh E, et al. Morphological characteristics of Epstein-Barr virus-related early gastric carcinoma : a case-control study. Pathol Int 1997 ; 47 (6) : 360-7.
PubMed
12) Song HJ, Srivastava A, Lee J, et al. Host inflammatory response predicts survival of patients with Epstein-Barr virusassociated gastric carcinoma. Gastroenterology 2010 ; 139 (1) : 84-92. e2.
 
13) Yanai H, Murakami T, Yoshiyama H, et al. Epstein-Barr virus-associated gastric carcinoma and atrophic gastritis. J Clin Gastroenterol 1999 ; 29 (1) : 39-43.
PubMed
14) Uemura Y, Tokunaga M, Arikawa J, et al. A unique morphology of Epstein-Barr virus-related early gastric carcinoma. Cancer Epidemiology Biomarkers Prev 1994 ; 3 (7) : 607-11.
 
15) Nishikawa J, Yanai H, Mizugaki Y, et al. Case report : hypoechoic submucosal nodules : a sign of Epstein-Barr virusassociated early gastric cancer. J Gastroenterol Hepatol 1998 ; 13 (6) : 585-90.
PubMed
16) Yanai H, Yahara N, Furuya T, et al. Long-Term Survival of Patient with Epstein-Barr Virus-Positive Gastric Cancer Treated with Chemotherapy : Case Report. J Gastrointest Cancer 2016 ; 47 (1) : 107-10.
PubMed

書評

最近チェックした商品履歴

Loading...